ProQR Therapeutics (PRQR) Q1 2026 Earnings
PRQR·Reported May 12, 2026·Before market open
ProQR Therapeutics reported Q1 2026 revenue of $2.3M (-52.6% YoY), missed analyst consensus of $5.2M by $2.8M. Diluted EPS came in at $-0.15 (-36.4% YoY).
Revenue
$2.3Mmissed by $2.8M
Consensus: $5.2MDiluted EPS
$-0.15met estimate
Consensus: $-0.15
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q1 2026 Earnings FAQ
Common questions about ProQR Therapeutics's Q1 2026 earnings report.
ProQR Therapeutics (PRQR) reported Q1 2026 earnings on May 12, 2026 before market open.
ProQR Therapeutics reported revenue of $2.3M and diluted EPS of $-0.15 for Q1 2026.
Revenue missed the consensus estimate of $5.2M by $2.8M. EPS beat the consensus estimate of $-0.15 by $0.00.
Compared to the same quarter a year prior, revenue declined 52.6% from $5.0M a year earlier and diluted EPS declined 36.4% from $-0.11.